These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intracerebral hemorrhage outcomes in patients using direct oral anticoagulants versus vitamin K antagonists: a meta-analysis. Ahmed A; Ahmed R; Ali SS; Patel U; Shahid I; Zafar M; Sharma A; Ashraf A; Jani V Clin Neurol Neurosurg; 2020 Nov; 198():106146. PubMed ID: 32823187 [TBL] [Abstract][Full Text] [Related]
8. Vitamin K antagonist-associated intracerebral hemorrhage: lessons from a devastating disease in the dawn of the new oral anticoagulants. Suárez-Pinilla M; Fernández-Rodríguez Á; Benavente-Fernández L; Calleja-Puerta S J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):732-42. PubMed ID: 23954605 [TBL] [Abstract][Full Text] [Related]
10. Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants. Purrucker JC; Haas K; Rizos T; Khan S; Wolf M; Hennerici MG; Poli S; Kleinschnitz C; Steiner T; Heuschmann PU; Veltkamp R JAMA Neurol; 2016 Feb; 73(2):169-77. PubMed ID: 26660118 [TBL] [Abstract][Full Text] [Related]
11. Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis. Boulouis G; Morotti A; Pasi M; Goldstein JN; Gurol ME; Charidimou A J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):263-270. PubMed ID: 29030422 [TBL] [Abstract][Full Text] [Related]
12. Similar outcomes between vitamin K and non-vitamin K antagonist oral anticoagulants associated intracerebral hemorrhage. Chen SJ; Yeh SJ; Tang SC; Lin SY; Tsai LK; Jeng JS J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):106-112. PubMed ID: 30876786 [TBL] [Abstract][Full Text] [Related]
13. MRI characteristics in acute ischemic stroke patients with preceding direct oral anticoagulant therapy as compared to vitamin K antagonists. Meinel TR; Kaesmacher J; Gralla J; Seiffge DJ; Auer E; Frey S; El-Koussy M; Arnold M; Fischer U; Göldlin M; Jung S; Hakim A BMC Neurol; 2020 Mar; 20(1):86. PubMed ID: 32160909 [TBL] [Abstract][Full Text] [Related]
14. Vitamin K antagonists but not non-vitamin K antagonists in addition on antiplatelet therapy should be associated with increase of hematoma volume and mortality in patients with intracerebral hemorrhage: A sub-analysis of PASTA registry study. Nomura K; Suda S; Abe A; Iguchi Y; Yagita Y; Kanzawa T; Okubo S; Fujimoto S; Kimura K; J Neurol Sci; 2023 May; 448():120643. PubMed ID: 37028263 [TBL] [Abstract][Full Text] [Related]
15. Outcomes of intraparenchymal hemorrhage after direct oral anticoagulant or vitamin K antagonist therapy: A systematic review and meta-analysis. DiRisio AC; Harary M; Muskens IS; Yunusa I; Gormley WB; Aglio LS; Smith TR; Connors JM; Mekary RA; Broekman MLD J Clin Neurosci; 2019 Apr; 62():188-194. PubMed ID: 30472344 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Traumatic Intracranial Hemorrhage Expansion and Outcomes Among Patients on Direct Oral Anticoagulants Versus Vitamin k Antagonists. Shin SS; Marsh EB; Ali H; Nyquist PA; Hanley DF; Ziai WC Neurocrit Care; 2020 Apr; 32(2):407-418. PubMed ID: 32034657 [TBL] [Abstract][Full Text] [Related]